Search research articles
Contact Us
Filters
Showing results (401-410 of 1,293) with videos related to
Page
of 130
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 13, 2009
Effect of patient satisfaction on outcomes of care
Meghan I Dubina, Jenna L O'Neill, Steven R Feldman
Dermatology Online Journal
|
March 25, 2014
Lack of information in current guidelines regarding systemic corticosteroids in inflammatory diseases
Ashley L Semble, Scott A Davis, Steven R Feldman
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
June 26, 2025
Commentary on Practical Interventions to Optimize Patient Adherence in Dermatologic Surgery and Mohs Micrographic Surgery
Chenan A Huang, Steven R Feldman, Laura B Doerfler
Journal of the American Academy of Dermatology
|
November 17, 2016
The most common dermatology diagnoses in the emergency department
Anish Nadkarni, Natalie Domeisen, Dane Hill, et al.
Dermatology Online Journal
|
March 23, 2017
Hypothyroidism in Patients with Psoriasis or Rosacea: A Large Population Study
Sara M James, Dane E Hill, Steven R Feldman
The Annals of Pharmacotherapy
|
April 20, 2023
A Review of Topical Tapinarof for the Treatment of Plaque Psoriasis
Meghan C Grossmann, Jessica N Pixley, Steven R Feldman
Journal of Cutaneous Medicine and Surgery
|
December 29, 2025
The Characterization of the Relationship Between Field Cancerization and Number of Actinic Keratoses
Stuti Prajapati, Christina Kontzias, Mallory Zaino, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 27, 2014
Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease
Steven R Feldman, William W Huang, Tu T Huynh
Southern Medical Journal
|
June 18, 2014
Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States
Scott A Davis, Daniel P Krowchuk, Steven R Feldman
Journal of the American Academy of Dermatology
|
October 29, 2025
Response to Papp et al, "Efficacy and safety of ESK-001, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: 52-week results from the long-term phase 2 study in patients who participated in the phase 2 STRIDE study"
Christiaan H Noot, Zachary H Hopkins, Steven R Feldman
Page
of 130
Search research articles
Search
Showing results (401-410 of 1,293) with videos related to
Sort By:
Page
of 130
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 13, 2009
Effect of patient satisfaction on outcomes of care
Meghan I Dubina, Jenna L O'Neill, Steven R Feldman
Dermatology Online Journal
|
March 25, 2014
Lack of information in current guidelines regarding systemic corticosteroids in inflammatory diseases
Ashley L Semble, Scott A Davis, Steven R Feldman
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
June 26, 2025
Commentary on Practical Interventions to Optimize Patient Adherence in Dermatologic Surgery and Mohs Micrographic Surgery
Chenan A Huang, Steven R Feldman, Laura B Doerfler
Journal of the American Academy of Dermatology
|
November 17, 2016
The most common dermatology diagnoses in the emergency department
Anish Nadkarni, Natalie Domeisen, Dane Hill, et al.
Dermatology Online Journal
|
March 23, 2017
Hypothyroidism in Patients with Psoriasis or Rosacea: A Large Population Study
Sara M James, Dane E Hill, Steven R Feldman
The Annals of Pharmacotherapy
|
April 20, 2023
A Review of Topical Tapinarof for the Treatment of Plaque Psoriasis
Meghan C Grossmann, Jessica N Pixley, Steven R Feldman
Journal of Cutaneous Medicine and Surgery
|
December 29, 2025
The Characterization of the Relationship Between Field Cancerization and Number of Actinic Keratoses
Stuti Prajapati, Christina Kontzias, Mallory Zaino, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 27, 2014
Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease
Steven R Feldman, William W Huang, Tu T Huynh
Southern Medical Journal
|
June 18, 2014
Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States
Scott A Davis, Daniel P Krowchuk, Steven R Feldman
Journal of the American Academy of Dermatology
|
October 29, 2025
Response to Papp et al, "Efficacy and safety of ESK-001, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: 52-week results from the long-term phase 2 study in patients who participated in the phase 2 STRIDE study"
Christiaan H Noot, Zachary H Hopkins, Steven R Feldman
Page
of 130